Robert N Fried
CIK 1417952 · Chief Executive Officer · last filed 2026-04-27
Robert N Fried is a Chief Executive Officer who has filed 44 SEC Form 4 insider transactions across 5 companies since 2007. The most recent filing shows the insider exercised options covering $52.2K of NAGE on Apr 27, 2026. Across all open-market trades the lifetime net is +$423.7K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $4.0M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$3.98M
5
44
$423.7K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| NAGE | Chief Executive Officer | 1,153,982 | $3.45 | $3.98M | $0 | 3 | 2026-04-27 |
| Niagen Bioscience, Inc. (CDXC) Delisted | Chief Executive Officer | 1,067,315 | $7.87 | $8.40M | $423.7K | 28 | 2025-02-27 |
| Fluent, Inc. (IDI) Delisted | Director | 318,671 | — | — | $0 | 5 | 2016-06-03 |
| Fluent, Inc. (IDI.WS) Delisted | President & CEO | — | — | — | $0 | 2 | 2010-01-13 |
| Ideation Acquisition Corp. (IDI.U) Delisted | President & CEO | 620,500 | — | — | $0 | 1 | 2007-11-28 |
Recent Filings
44 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-04-27 | NAGE | Exer (M) | +20,000 | $52.2K | EDGAR |
| 2026-02-24 | NAGE | Grant (A) | — | $0 | EDGAR |
| 2025-04-09 | NAGE | Exer (M) | +66,667 | $220.0K | EDGAR |
| 2025-02-27 | Niagen Bioscience, Inc. (CDXC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2025-02-14 | Niagen Bioscience, Inc. (CDXC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-02-23 | Niagen Bioscience, Inc. (CDXC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-06-01 | Niagen Bioscience, Inc. (CDXC) Delisted | Buy (P) | +7,000 | $9.9K | EDGAR |
| 2023-02-17 | Niagen Bioscience, Inc. (CDXC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-10-03 | Niagen Bioscience, Inc. (CDXC) Delisted | Buy (P) | +80,000 | $100.0K | EDGAR |
| 2022-03-16 | Niagen Bioscience, Inc. (CDXC) Delisted | Buy (P) | +25,000 | $54.0K | EDGAR |